Opinion|Videos|July 16, 2024

Differentiating Between the Semi-Fluorinated Alkane-Based Therapies for Dry Eye

Selina McGee, OD, FAAO, discusses the role of cyclosporine ophthalmic solution (VEVYE) in the treatment of dry eye disease.

Video content above is prompted by the following questions:

  • When do you prefer to use cyclosporine ophthalmic solution, 0.1% (VEVYE)? How are the indications for this drug different from perfluorohexyloctane ophthalmic solution?

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.


Latest CME